Skip to main content

Table 4 Clinical and laboratory findings in complete KD in the 2000–2004 group and the 2010–2014 group (n = 387)

From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea

 

2000–2004 (n = 210)

2010–2014 (n = 177)

P

Age (month)

30.9 ± 21.5

31 ± 18.9

0.938

Sex (M/F)

124/86

109/68

0.677

Fever (day)

 Preadmission

4.8 ± 1.8

4.3 ± 1.6

0.009

 Total

6.9 ± 2.9

6.5 ± 2.3

0.392

Hospitalization (d)

8.5 ± 4.1

6.5 ± 2.8

< 0.001

Repeated IVIG, n (%)

24 (11.4)

22 (12.4)

0.754

CALs, n (%)

45 (21.4)

28 (15.8)

0.192

 Ectasia

42 (20)

27 (15.3)

0.234

 Aneurysm

3 (1.4)

1 (0.6)

0.629

WBC (/mm3)

15,100 ± 5100

15,000 ± 5200

0.880

Neutrophil (%)

64.5 ± 16.2

67.9 ± 14.2

0.031

 Lymphocyte (%)

22.8 ± 12.8

22.1 ± 12.1

0.561

 Hemoglobin (g/dL)

10.8 ± 1.2

11.5 ± 0.8

< 0.001

Platelet (/mm3)

315 ± 147

332 ± 89

0.122

Platelet, follow-up

501 ± 208

443 ± 161

< 0.001

CRP (mg/dL)

10.4 ± 6.8

9.5 ± 5.6

0.192

ESR (mm/h)

56 ± 24

74 ± 32

< 0.001

Total protein (g/dL)

6.5 ± 0.7

6.5 ± 0.6

0.656

Albumin (g/dL)

3.5 ± 0.4

3.8 ± 0.5

< 0.001

AST (IU/L)

89 ± 166

104 ± 156

0.338

ALT (IU/L)

127 ± 161

126 ± 149

0.928

ALT <40 IU, n (%)

89 (42.4)

75 (42.4)

0.918

ALT 40–100 IU, n (%)

45 (21.4)

36 (20.3)

0.900

ALT >100 IU, n (%)

76 (36.2)

66 (37.3)

0.750

  1. Values are mean ± SD or n (%). Abbreviations as in Table 1